Congenital or early infantile CACH syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:157713OMIM:603896E75.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital or early infantile CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) is the most severe form of vanishing white matter disease (VWM), also known as leukoencephalopathy with vanishing white matter. This form presents at birth or within the first year of life and follows a rapidly progressive course. It is caused by biallelic pathogenic variants in one of the five genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1, EIF2B2, EIF2B3, EIF2B4, or EIF2B5). These genes are essential for protein synthesis in all cells, but the brain's white matter is particularly vulnerable, leading to progressive destruction and cystic degeneration of cerebral white matter. The congenital and early infantile forms represent the most severe end of the VWM disease spectrum. Affected infants may present with severe neurological decline from birth, including progressive spasticity, cerebellar ataxia, seizures, feeding difficulties, and failure to thrive. Congenital cases may show additional features such as cataracts, hepatosplenomegaly, renal abnormalities, and ovarian dysgenesis (in females). Brain MRI characteristically shows diffuse white matter abnormalities with areas of cystic degeneration and rarefaction, giving the appearance of 'vanishing' white matter. Neurological deterioration is often rapid and can be triggered or worsened by febrile infections, minor head trauma, or other physiological stressors. There is currently no cure or disease-modifying treatment for congenital or early infantile CACH syndrome. Management is supportive and symptomatic, focusing on seizure control, nutritional support, physical therapy, and prevention of known triggers of neurological deterioration such as fever and infections. The prognosis for this severe form is poor, with most affected children experiencing rapid neurological decline and significantly shortened life expectancy, often dying within the first few years of life. Genetic counseling is recommended for affected families.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital or early infantile CACH syndrome.

View clinical trials →

No actively recruiting trials found for Congenital or early infantile CACH syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital or early infantile CACH syndrome community →

No specialists are currently listed for Congenital or early infantile CACH syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital or early infantile CACH syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital or early infantile CACH syndromeForum →

No community posts yet. Be the first to share your experience with Congenital or early infantile CACH syndrome.

Start the conversation →

Latest news about Congenital or early infantile CACH syndrome

No recent news articles for Congenital or early infantile CACH syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital or early infantile CACH syndrome

What is Congenital or early infantile CACH syndrome?

Congenital or early infantile CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) is the most severe form of vanishing white matter disease (VWM), also known as leukoencephalopathy with vanishing white matter. This form presents at birth or within the first year of life and follows a rapidly progressive course. It is caused by biallelic pathogenic variants in one of the five genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1, EIF2B2, EIF2B3, EIF2B4, or EIF2B5). These genes are essential for protein synthesis in all cells, but the brain's

How is Congenital or early infantile CACH syndrome inherited?

Congenital or early infantile CACH syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Congenital or early infantile CACH syndrome typically begin?

Typical onset of Congenital or early infantile CACH syndrome is neonatal. Age of onset can vary across affected individuals.